))
Life Science Series: Risks for multinational pharmaceuticals in India
Manage episode 438501961 series 3025582
Content provided by Control Risks. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Control Risks or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
India is an important market for many multinational pharmaceutical, biotech or medical device companies. But it is also a challenging one.
Join Martina Rozumberkova for a conversation with Sushmit Bhattacharya about challenges facing multinational pharmaceutical companies operating in India, from important regulatory changes, including the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, to emerging fraud schemes, including fraud in the Government e-Marketplace (GeM) and retailer incentive schemes.
20 episodes
Share
